LC-MS/MS-based serum proteomics for identification of candidate biomarkers for hepatocellular carcinoma.
about
Integrative analysis of LC-MS based glycomic and proteomic data.Integrative Analysis of Multi-omics Data for Discovery and Functional Studies of Complex Human Diseases.Integrative Analysis of Proteomic, Glycomic, and Metabolomic Data for Biomarker Discovery.Topic model-based mass spectrometric data analysis in cancer biomarker discovery studiesINDEED: Integrated differential expression and differential network analysis of omic data for biomarker discovery.On the privacy risks of sharing clinical proteomics dataIdentification of novel serum peptides biomarkers for female breast cancer patients in Western China.Mass spectrometric identification of phenol-soluble modulins in the ATCC® 43300 standard strain of methicillin-resistant Staphylococcus aureus harboring two distinct phenotypes.Quantitative proteomic analysis identifies new effectors of FOXM1 involved in breast cancer cell migration.Deciphering glycomics and neuroproteomic alterations in experimental traumatic brain injury: Comparative analysis of aspirin and clopidogrel treatment.Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.Recent Advances in the Analysis of Complex Glycoproteins.Identification of circulating protein biomarkers in patients with hepatocellular carcinoma concomitantly infected with chronic hepatitis C virus.Identification and functional analysis of differentially expressed genes in poorly differentiated hepatocellular carcinoma using RNA-seq.Transcriptome profiling identifies a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma.Glycoprotein Enrichment Analytical Techniques: Advantages and Disadvantages.Proteomic and N-glycoproteomic quantification reveal aberrant changes in the human saliva of oral ulcer patients.
P2860
Q31035522-3A04308C-8DA7-43F5-9CAC-32DCB63D750AQ31049198-17F47054-CBAB-44C4-9E71-1F2CC23D051DQ31104649-04EEA9A9-6884-4F95-8470-A4ACD4EBED2BQ31122171-CBE0B5CC-37BB-466D-B738-F127321D43A0Q31126623-8CF06109-B4E1-4101-B3B8-4F4ED78E6497Q31126754-E1AD8061-5A86-49E0-9CAF-0023B84B9BC1Q35878626-B64E990C-9CA5-4FB8-881A-506CE2BDA476Q36250441-EEC6E0A0-E6DB-4D45-9EAC-FEE52E48AF34Q36511744-8CC70573-0470-46B8-976C-034415B3045FQ37132873-BC5C39A2-D784-43FC-9823-27568DBA175AQ38635611-E29A6F72-6E54-46EC-8553-3284786B2570Q39096219-2742CE64-EA84-4410-AB9E-E09B1FEBA8DCQ40479346-7A6DFD3A-9310-4261-80A3-A1523468CFAEQ41056051-DC7E9AF2-CD16-401C-865A-B9732EE24678Q41093037-659123CB-F7EC-44A7-8C44-7F2D4FE6F905Q49812897-D1250267-E615-428E-ABA0-0E010A0C772EQ51373204-B113F043-7A14-4D0A-B67B-F1592D6220A8
P2860
LC-MS/MS-based serum proteomics for identification of candidate biomarkers for hepatocellular carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
LC-MS/MS-based serum proteomic ...... for hepatocellular carcinoma.
@ast
LC-MS/MS-based serum proteomic ...... for hepatocellular carcinoma.
@en
type
label
LC-MS/MS-based serum proteomic ...... for hepatocellular carcinoma.
@ast
LC-MS/MS-based serum proteomic ...... for hepatocellular carcinoma.
@en
prefLabel
LC-MS/MS-based serum proteomic ...... for hepatocellular carcinoma.
@ast
LC-MS/MS-based serum proteomic ...... for hepatocellular carcinoma.
@en
P2093
P2860
P356
P1433
P1476
LC-MS/MS-based serum proteomic ...... s for hepatocellular carcinoma
@en
P2093
Chirag S Desai
Cristina Di Poto
Dina Hazem Ziada
Ehwang Song
Habtom W Ressom
Kirti Shetty
Mahlet G Tadesse
Minkun Wang
Rency S Varghese
P2860
P304
P356
10.1002/PMIC.201400364
P577
2015-04-29T00:00:00Z